Previous product
Back to products
Inrebic (fedratinib)
CHF6,421.16
Next product
Piqray (alpelisib)
CHF7,700.00
Tibsovo (ivosidenib)
CHF38,438.32
Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have:
- Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, or
- Locally advanced or metastatic bile duct cancer (cholangiocarcinoma)
Reviews
There are no reviews yet.